Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Clinical Research Program Leader, Hematology Program, Yale Cancer Center
Multiple myeloma; monoclonal gammopathy of unknown significance (MGUS); immunobiology of cancers
Accepts New Patients?
Patient Type: Adult
Accepts appointments from patients or physicians
A Phase 2 Biomarker Study of Elotuzumab (Humanized anti-CS1 Monoclonal IgG1 Antibody) Monotherapy to Assess the Association Between NK Cell Status and Efficacy in High Risk Smoldering Myeloma
Disease/Condition: Smoldering Myeloma